Key facts
- It has raised $500K; the latest was Angel (individual) in Jun 2025.
- Notable investors include LaunchVic, Australia's Economic Accelerator, GrantConnect, Medtech Actuator.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Haemograph
- ·The full record, as it builds
Funding rounds
No funding rounds for Haemograph are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Haemograph
Developer of a medtech product intended to improve accuracy and efficiency in patient care. The company offers a portable point-of-care blood coagulation rheometer and a patented bubble-free syringe system designed to improve accuracy and safety in clinical settings, enabling clinicians to enhance treatment outcomes and minimize needle-stick injuries.
- Sector
- Healthcare
- HQ
- Bayswater, Australia
- Founded
- 2017
- Employees
- 6
- Website
- haemograph.com.au/
- Ownership
- Privately Held (backing)
Haemograph doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Haemograph shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Haemograph in its N-PORT filings yet. We sweep new filings monthly.